Współczesna Onkologia

Evaluation of the utility of whole-exome sequencing in patients with atypical clinical features of oncohematologic diseases

Wojciech Czogała 1, 2
,
Wojciech Kowalczyk 3, 4
,
Kacper Szczepan Żurek 5
,
Elżbieta Trzyna 2
,
Karol Miklusiak 6, 7
,
Agnieszka Łazarczyk 8
,
Julia Krupa-Zabiegała 9
,
Walentyna Balwierz 1, 2
,
Szymon Skoczeń 1, 2

  1. Department of Paediatric Oncology and Haematology, Faculty of Medicine, Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland

  2. University Children’s Hospital of Cracow, Cracow, Poland

  3. Department of Transplantology, Chair in Clinical Immunology and Transplantology, Faculty of Medicine, Institute of Paediatrics, Jagiellonian University Medical College, Cracow, Poland

  4. Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Cracow, Poland

  5. University Hospital in Cracow, Cracow, Poland

  6. Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland

  7. Department of Human Nutrition and Metabolomics, Pomeranian Medical University, Szczecin, Poland

  8. Department of Pathomorphology, Jagiellonian University Medical College, Cracow, Poland

  9. Student Scientific Group of Paediatric Oncology

Contemp Oncol (Pozn) 2026; 30 (3)

DOI: https://doi.org/10.5114/wo.2026.164606
Data publikacji online: 2026/10/19
Article file
Evaluation of the utility.pdf
  1. Wagener R, Taeubner J, Walter C, Yasin L, Alzoubi D, Bartenhagen C, et al. Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer. Eur J Hum Genet 2021; 29: 1301-1311.
  2. Furutani E, Shimamura A. Germline genetic predisposition to hematologic malignancy. J Clin Oncol 2017; 35: 1018-1028.
  3. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013; 369: 1502-1511.
  4. Chung CCY, Hue SPY, Ng NYT, Doong PHL, Chu ATW, Chung BHY. Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations. Genet Med 2023; 25: 100896.
  5. Pandey R, Brennan NF, Trachana K, Katsandres S, Bodamer O, Belmont J, et al. A meta-analysis of diagnostic yield and clinical utility of genome and exome sequencing in pediatric rare and undiagnosed genetic diseases. Genet Med 2025; 27: 101398.
  6. Lavelle TA, Feng X, Keisler M, Cohen JT, Neumann PJ, Prichard D, et al. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions. Genet Med 2022; 24: 1349-1361.
  7. Stark Z, Schofield D, Martyn M, Wilson W, Mupfeki N, Macciocca I, et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early WES. Genet Med 2017; 19: 867-874.
  8. Posey JE, Rosenfeld JA, James RA, Bainbridge M, Niu Z, Wang X, et al. Molecular diagnostic experience of whole-exome sequencing in adult patients. Genet Med 2016; 18: 678-85.
  9. Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence- based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021; 23: 2029-2037.
  10. Skoczen S, Stepien K, Krzysztofik M, Luszawska T, Hnatko-Kolacz M, Korostynski M, et al. Genetic profile and clinical implications of hepatoblastoma and neuroblastoma coexistence in a child. Front Oncol 2019; 9: 230.
  11. Skoczen S, Stepien K, Mlynarski W, Centkowski P, Kwiecinska K, Korostynski M, et al. Genetic signature of acute lymphoblastic leukemia and netherton syndrome co-incidence-first report in the literature. Front Oncol 2019; 9: 1477.
  12. Parsons DW, Roy A, Yang Y, Wang T, Scollon S, Bergstrom K, et al. Diagnostic yield of clinical tumor and germline whole-exome seque- ncing for children with solid tumors. JAMA Oncol 2016; 2: 616-624.
  13. Langenberg KPS, Meister MT, Bakhuizen JJ, Boer JM, van Eijkelenburg NKA, Hulleman E, et al. Implementation of paediatric precision oncology into clinical practice: the individualized therapies for children with cancer program “iTHER”. Eur J Cancer 2022; 175: 311-325.
  14. Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, et al. Germline mutations in predisposition genes in pediatric cancer. Nature 2015; 520: 230-235.
  15. Vodicska B, Déri J, Tihanyi D, Várkondi E, Kispéter E, Dóczi R, et al. Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors. World J Pediatr 2023; 19: 992-1008.
  16. Mekchay P, Ittiwut C, Ittiwut R, Akkawat B, Le Grand SM, Leela- Adisorn N, et al. Whole exome sequencing for diagnosis of hereditary thrombocytopenia. Medicine 2020; 99: 23275.
  17. Mordaunt DA, Gonzalez FS, Lunke S, Eggers S, Sadedin S, Chong B, et al. The cost of proband and trio exome and genome analysis in rare disease: a micro-costing study. Genet Med 2024; 26: 101058.
  18. Del Gobbo GF, Boycott KM. The additional diagnostic yield of long-read sequencing in undiagnosed rare diseases. Genome Res 2025; 35: 559-571.
  19. Zou YS, Klausner M, Ghabrial J, Stinnett V, Long P, Morsberger L, et al. A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping. Blood Cancer J 2024; 14: 78.
  20. Levy B, Baughn LB, Akkari Y, Chartrand S, LaBarge B, Claxton D, et al. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation. Blood Adv 2023; 7: 1297-1307.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications